Patents
More topics under "A61P - Specific therapeutic activity of chemical compounds or medicinal preparations" (2,008,710)
A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
A61P 11 - Drugs for disorders of the respiratory system (87,767)
A61P 13 - Drugs for disorders of the urinary system (56,135)
A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
A61P 17 - Drugs for dermatological disorders (106,455)
A61P 19 - Drugs for skeletal disorders (81,981)
A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
A61P 23 - Anaesthetics (4,141)
A61P 25 - Drugs for disorders of the nervous system (183,225)
A61P 27 - Drugs for disorders of the senses (53,017)
A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
A61P 3 - Drugs for disorders of the metabolism (129,789)
A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
A61P 33 - Antiparasitic agents (21,787)
A61P 35 - Antineoplastic agents (221,099)
A61P 37 - Drugs for immunological or allergic disorders (117,141)
A61P 39 - General protective or antinoxious agents (19,019)
A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707)
A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
A61P 5 - Drugs for disorders of the endocrine system (28,908)
A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
Patents for A61P - Specific therapeutic activity of chemical compounds or medicinal preparations (3,181)
08/2004
08/11/2004EP1135381B1 Eletriptan hydrobromide monohydrate
08/11/2004CN1520403A Novel polymorph v of torasemide
08/11/2004CN1161351C Novel form of S-omeprazole
08/11/2004CN1161120C Utilization of polycyclic 2-amino-thiazole systems in the production of medicaments for prophylasis treatment of obesity
08/10/2004US6774122 Sustained release; injection of fulvestrant
08/05/2004US20040152771 Mixture with biguanidine drug; antidiabetic agents; insulin resistance
08/04/2004CN1518543A Pyrazole derivatives and their use as protein kinase inhibitors
08/04/2004CN1518542A Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
08/04/2004CN1518462A Pharmaceutical formulation
07/2004
07/29/2004US20040147600 Mixture of drug with insulin; antidiabetic agents
07/29/2004US20040147541 Using rapamycin; antitumor agents; angiogenesis inhibitors
07/29/2004US20040147508 Biologically active methylene blue derivatives
07/28/2004EP1439823A1 Pharmaceutical formulation comprising (r)-bicalutamide
07/28/2004CN1159014C Use of 4 alpha-methyl-17 alpha-ethyle-estrane derivative for treatment of atherosclerosis
07/28/2004CN1158997C A process for the preparation of suspensions of drug particles for inhalation delivery
07/21/2004EP1438959A1 Controlled release oxycodone compositions
07/21/2004EP1438291A1 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
07/21/2004EP1438037A1 Methods for treating dry eye by a combination of an antiinflammatory steroid and a muc-1 secretagogue
07/21/2004EP1228029B1 Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders
07/21/2004EP1226137B1 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity
07/21/2004CN1514828A Pyrazole derivatives for treating HIV
07/21/2004CN1158276C Phenyl-and pyridyl-tetrahydro-pyridines having TNF inhibiting activity
07/21/2004CN1158070C Immediate release tablet
07/20/2004CA2216634C Synergistic combinations of zidovudine, 1592u89 and 3tc or ftc
07/15/2004US20040138267 Antitumor agents
07/14/2004EP1228067B1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity
07/14/2004EP1224179B1 Sodium-hydrogen exchanger type 1 inhibitor crystals
07/14/2004EP1140102B1 Triazineone compounds for treating diseases due to neospora and toxoplasma
07/14/2004CN1512985A Aimoquinoline and aminopyridine derivatives and their use as adenosine A3 ligands
07/14/2004CN1157221C Health compsn.
07/14/2004CN1157196C Galenic preparation for prevetion and treatment of hepatocarcinoma
07/13/2004US6762204 Taxol enhancer compounds
07/08/2004WO2004032949A8 Argyrolobium roseum plant extracts for treating diabetes
07/08/2004US20040133031 Crystal of bicalutamide and production method thereof
07/08/2004US20040132781 Pyrazole compounds useful as protein kinase inhibitors
07/07/2004EP1434624A1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors
07/07/2004CN1511152A N-formyl hydroxylamine compounds as PDF inhibitor
07/07/2004CN1156454C Pyrimidine-2,4,6-trione metalloproteinase inhibitors
06/2004
06/30/2004CN1509288A The citrate salt of 5,8,14-triazatetracyclo (10.3.1.0.2,11.0.4,9)-hexadeca-2.(11),3,5,7,9-pentaene
06/30/2004CN1509174A Tartrate salt of 5,8,14-triazatetracyclo [10,3,1,02,11.04,9]-hexzdeca-2(11),3,5,7,9-pentaene
06/30/2004CN1155378C Antitumour synergistic composition
06/29/2004US6756377 Compounds and their use
06/24/2004WO2004052384A1 Antiviral, anti-infectious and cicatrising properties of extracts of dichrostachys glomerata
06/24/2004US20040122055 C10 carbonate taxane compositions
06/24/2004US20040121979 Pharmaceutically active uridine esters
06/24/2004CA2526901A1 Antiviral, anti-infectious and cicatrising properties of extracts of dichrostachys glomerata
06/23/2004EP1429807A2 Combination of a nsaid and a pde-4 inhibitor
06/23/2004EP1429754A1 Combination of selected opioids with muscarine antagonists for treating urinary incontinence
06/23/2004CN1154497C Method of treatment of lever tumours and pharmaceutical compositions for use therein
06/22/2004US6753013 Vitamin d or vitamin d analogue; a corticosteroid; solvent; topical
06/17/2004WO2003032810A3 Treatment and diagnosis of insulin resistant states
06/16/2004EP1427711A1 Oxazolidinone and/or isoxazoline derivatives as antibacterial agents
06/16/2004EP1427423A1 Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia
06/16/2004EP1427414A1 Inhalation compositions comprising tricyclic 5,6-dihydro-9h-pyrazolo (3,4-c)-1,2,4-triazolo (4,3-alpha) pyridines
06/16/2004EP1268469B1 N-(heterocyclyl)benzene or pyridine sulphonamides as antithrombotic agents and anticoagulants
06/16/2004EP1255751B1 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b or v1b and v1a arginine-vasopressin receptors
06/16/2004EP1196418B1 METHOD FOR PREPARING SUBSTITUTED 1,4]DIAZEPINO 6,7,1- i hi /i ]INDOL-4-ONES
06/16/2004CN1505636A Pharmaceutically active uridine esters
06/16/2004CN1505631A Substituted pyrazinoquinoxaline derivatives as serotonin receptor agonist and antagonists ligands
06/16/2004CN1505614A Process for making amlodipine maleate
06/16/2004CN1505506A Carbamate compounds for use in preventing or treating bipolar disorder
06/16/2004CN1153780C Protein with thrombopoiesis substance activity
06/15/2004US6750245 C7 carbamate substituted taxanes
06/10/2004US20040109902 Dermatological formulations
06/09/2004EP1425008A1 Use of substituted aminomethyl chromans in the treatment of movement disorders
06/09/2004EP1425005A1 Pharmaceutical compostion comprising lumiracoxib
06/09/2004EP1198237B1 Herbal compositions for itchy or infected skin
06/09/2004EP1180102B1 Mutual prodrugs of amlodipine and atorvastatin
06/09/2004CN1503784A 2-lminopyrrolidine derivatives
06/08/2004US6747158 Anticoagulants
06/03/2004WO2004046115A1 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors
06/03/2004WO2004045718A2 Treatment of cognitive dysfunctions'
06/03/2004WO2003032995A8 Rosuvastatin in pre demented states
06/03/2004US20040106664 11-Beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
06/03/2004US20040106547 glucose lowering protein (GLP-1); exendins; for regulation of excess levels of blood glucose and/or regulation of gastric emptying; for treatment of diabetes and eating disorders
06/03/2004US20040105887 Controlled release oxycodone compositions
06/03/2004US20040103902 Condom with an erectogenic composition
06/02/2004EP1423393A1 Cyclic indole and heteroindole derivatives, the production and use thereof as medicaments
06/02/2004EP1423124A2 Lyophilized formulation comprising olanzapine
06/02/2004EP1423101A1 Plaster for the treatment of dysfunctions and disorders of nails
06/02/2004CN1501937A Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
06/02/2004CN1152014C N-aryl anthranilic acid derivatives and uses thereof
05/2004
05/27/2004WO2004028521A3 Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders
05/27/2004US20040102414 Methods and compositions for treating flaviviruses and pestiviruses
05/27/2004US20040101579 Isoflavones and saponins in defined ratios, menopause, cancer
05/26/2004EP1421105A1 Anti-cancer cyclopenta[g]quinazoline compounds
05/26/2004EP1421083A1 Novel imidazopyridine compounds with therapeutic effect
05/26/2004EP1420815A2 Beta-amyloid-analogue - t-cell epitop vaccine
05/26/2004EP1173176B1 Utilization of polycyclic 2-amino-thiazole systems in the production of medicaments for prophylaxis or treatment of obesity
05/26/2004EP1117652B1 Tan-1057 derivatives
05/25/2004US6740770 Crystal of bicalutamide and production method thereof
05/20/2004US20040097462 Methods and compositions for treating flaviviruses and pestiviruses
05/20/2004US20040096500 Reducing the range in daily dosages required to control pain in approximately 90% of patients is disclosed whereby an oral solid controlled release dosage formulation having from about 10 to about 40 mg of oxycodone or a salt thereof is
05/19/2004EP1419776A2 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
05/19/2004EP1419150A2 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
05/19/2004EP1418924A2 Single dose azithromycin for treating respiratory infections
05/19/2004CN1498212A New spirotricyclic derivatives and their use as phosphodiesterase-7-inhibitors
05/19/2004CN1498096A Condom with erectogenic composition
05/13/2004WO2004019960A3 Herbal extract comprising a mixture of saponins obtained from sapindus trifoliatus for anticonvulsant activity
05/13/2004US20040092502 Central nervous system disorders; dietetics; psychological disorders; sleep disorders; sexual disorders
1 ... 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 ... 32